Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $824.96 billion, total revenue of $166.46 billion and a weighted average PE ratio of 53.40.
Market Cap
824.96B
Revenue
166.46B
Profits
15.45B
PE Ratio
53.40
Profit Margin
9.28%
Dividend Yield
0.19%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 235.19B | -2.11% | 2,847,777 | 43.74B |
| 2 | DHR | Danaher Corporation | 166.00B | -2.11% | 3,066,967 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.40B | 0.41% | 279,294 | 4.17B |
| 4 | IQV | IQVIA Holdings Inc. | 40.07B | -1.56% | 683,327 | 15.90B |
| 5 | A | Agilent Technologies, Inc. | 38.29B | -2.58% | 1,811,644 | 6.95B |
| 6 | NTRA | Natera, Inc. | 33.42B | -0.55% | 961,084 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.73B | -2.21% | 123,725 | 3.94B |
| 8 | WAT | Waters Corporation | 23.36B | -2.03% | 581,388 | 3.11B |
| 9 | ILMN | Illumina, Inc. | 22.96B | -2.38% | 2,765,007 | 4.29B |
| 10 | LH | Labcorp Holdings Inc. | 22.11B | -1.23% | 445,461 | 13.77B |
| 11 | DGX | Quest Diagnostics Incorporated | 20.14B | -0.63% | 848,894 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.41B | -0.11% | 1,857,838 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.56B | -3.01% | 301,649 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 14.78B | -2.16% | 1,466,406 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 14.27B | 0.07% | 515,759 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 13.23B | -0.87% | 1,396,239 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 11.46B | 2.53% | 4,319,934 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 10.81B | -1.97% | 576,850 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.65B | 0.27% | 530,750 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.26B | -2.06% | 1,515,920 | 1.15B |
| 21 | GRAL | GRAIL, Inc. | 4.09B | -9.62% | 1,222,447 | 141.83M |
| 22 | BLLN | BillionToOne, Inc. | 4.01B | -3.30% | 141,238 | 254.14M |
| 23 | VCYT | Veracyte, Inc. | 3.34B | -3.49% | 1,239,223 | 495.14M |
| 24 | WGS | GeneDx Holdings Corp. | 2.93B | -0.52% | 592,774 | 402.19M |
| 25 | TWST | Twist Bioscience Corporation | 2.63B | -4.89% | 1,126,005 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.13B | -1.31% | 7,260,316 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.66B | -1.23% | 3,025,283 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.23B | 0.21% | 371,273 | 343.53M |
| 29 | CDNA | CareDx, Inc. | 1.05B | -2.85% | 623,291 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 1.01B | -2.94% | 966,036 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 903.14M | -9.60% | 1,557,933 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 859.98M | -1.24% | 145,326 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 547.16M | -3.14% | 806,155 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 377.58M | -14.59% | 30,947 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 309.98M | -2.54% | 238,378 | 77.08M |
| 36 | MDXH | MDxHealth SA | 187.59M | -8.67% | 207,017 | 103.07M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 186.89M | -2.40% | 39,903 | 4.40M |
| 38 | FONR | FONAR Corporation | 121.92M | -0.05% | 71,264 | 105.43M |
| 39 | XGN | Exagen Inc. | 104.25M | -5.93% | 459,818 | 63.60M |
| 40 | BDSX | Biodesix, Inc. | 93.40M | 5.77% | 498,663 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.01M | 0.70% | 12,843 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 18.91M | -4.25% | 110,738 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.69M | - | 610,759 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 9.12M | -2.61% | 16,298 | - |
| 45 | ADVB | Advanced Biomed Inc. | 6.91M | -6.23% | 75,990 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 6.06M | -0.74% | 39,570 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.19M | -5.12% | 13,139 | - |
| 48 | ISPC | iSpecimen Inc. | 3.75M | -0.31% | 555,752 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 1.99M | 2.86% | 484,352 | 29.52M |